These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6116775)

  • 1. Free fraction change with differing volume ratios in equilibrium dialysis: cases of non-linear drug-protein binding.
    Behm HL; Wagner JG
    J Pharm Pharmacol; 1981 May; 33(5):283-9. PubMed ID: 6116775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Errors in interpretation of data from equilibrium dialysis protein binding experiments.
    Behm HL; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):145-60. PubMed ID: 515500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):19-40. PubMed ID: 8027947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding of tolmetin.
    Selley ML; Madsen BW; Thomas J
    Clin Pharmacol Ther; 1978 Dec; 24(6):694-705. PubMed ID: 710027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs.
    Decroix MO; Zini R; Chaumeil JC; Tillement JP
    Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: Fatty acids influence the HSA-metabolite interaction.
    Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
    J Magn Reson; 2013 Mar; 228():81-94. PubMed ID: 23357430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects of free drug concentration determination in human serum with equilibrium dialysis.
    van der Giesen WF; Wilting J
    Methods Find Exp Clin Pharmacol; 1982; 4(6):417-23. PubMed ID: 7144334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid binding to human serum albumin and human plasma: effects of pH variation and buffer composition in equilibrium dialysis.
    Albani F; Riva R; Contin M; Baruzzi A
    Ther Drug Monit; 1984; 6(1):31-3. PubMed ID: 6424277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parabolic equation relating free and total drug concentrations in cases of nonlinear plasma protein binding.
    Behm HL; Wagner JG
    J Pharm Sci; 1981 Jul; 70(7):802-4. PubMed ID: 7264932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein binding of drugs during and after pregnancy in humans.
    Dean M; Stock B; Patterson RJ; Levy G
    Clin Pharmacol Ther; 1980 Aug; 28(2):253-61. PubMed ID: 7398192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: a comparison between equilibrium dialysis and fluorescence titration.
    Ozer I; Tacal O
    Anal Biochem; 2001 Jul; 294(1):1-6. PubMed ID: 11411999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of pH, calcium and chloride ions on the binding of tolmetin to human serum albumin: circular dichroic, dialysis and fluorometric measurements.
    Matsuyama K; Sen AC; Perrin JH
    J Pharm Pharmacol; 1987 Mar; 39(3):190-5. PubMed ID: 2883283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium oleate on salicylic acid binding to human serum albumin.
    Schwartz PA; Greene DS; Rhodes CT
    J Pharm Sci; 1980 Nov; 69(11):1345-8. PubMed ID: 7452469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of obesity and ancillary variables (dialysis time, drug, albumin, and fatty acid concentrations) on theophylline serum protein binding.
    Shum L; Jusko WJ
    Biopharm Drug Dispos; 1989; 10(6):549-62. PubMed ID: 2611356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.
    Tozer TN; Gambertoglio JG; Furst DE; Avery DS; Holford NH
    J Pharm Sci; 1983 Dec; 72(12):1442-6. PubMed ID: 6663482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.